NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: C000000203

Registered date:13/09/2005

Prevention of hepatocellular carcinoma in patients with chronic hepatitis C and cirrhosis by pegylated IFN-alpha-2a after surgical resection or radiofrequency ablation

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedchronic hepatitis C,cirrhosis,hepatocellular carcinoma
Date of first enrollment2003/06/01
Target sample size100
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)PEG-IFN-alpha2a no treatment

Outcome(s)

Primary OutcomePrevention of hepatocellular carcinoma
Secondary OutcomeHCV-RNA,ALT,fibrosis

Key inclusion & exclusion criteria

Age minimumNot applicable
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteriaANC<750/mm3,Plt<50,000/mm3 Child-Pugh B,C

Related Information

Contact

public contact
Name Ken Sato
Address 3-39-22 Showa, Maebashi, Gunma 371-8511, Japan Japan
Telephone 027-220-8127
E-mail satoken@gunma-u.ac.jp
Affiliation Gunma University Graduate School of Medicine Department of Medicine and Molecular Science
scientific contact
Name Ken Sato
Address 3-39-22 Showa, Maebashi, Gunma 371-8511, Japan Japan
Telephone 027-220-8127
E-mail satoken@gunma-u.ac.jp
Affiliation Gunma University Graduate School of Medicine Department of Medicine and Molecular Science